Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIA Open Label Trial of Memantine in Combination With Riluzole (Customary Care) for the Treatment of ALS

NCT01020331 is registered in ClinicalTrials.gov with Phoenix Neurological Associates, LTD as lead sponsor.

NCT NCT01020331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01020331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIA Open Label Trial of Memantine in Combination With Riluzole (Customary Care) for the Treatment of ALS
Lead sponsor
Phoenix Neurological Associates, LTD
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis